9 Results for "

AMPA Receptor Potentiator

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "AMPA Receptor Potentiator" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-10935
CAS No.: 376594-67-1
Purity:  99.51%
Target:  

iGluR

Research Areas:  

Neurological Disease

LY450108 is a potent AMPA receptor potentiator. LY450108 has the potential for depression and Parkinson's disease research .
loading...
    loading...
Cat. No.: HY-10934
CAS No.: 375345-95-2
Purity:  99.86%
Synonyms: LY451395
Target:  

iGluR

Research Areas:  

Neurological Disease

Mibampator (LY451395) is a potent and highly selective potentiator of the AMPA receptors.
loading...
    loading...
Cat. No.: HY-12509
CAS No.: 141286-78-4
Purity:  99.87%
Target:  

iGluR

Research Areas:  

Neurological Disease

PEPA is an AMPA receptor allosteric potentiator. PEPA shows preferential action of PEPA on the flop form of AMPA receptors. PEPA is a more potent suppressor of desensitization of receptors containing GluR3 and GluR4 as opposed to those containing GluR1. PEPA has antianxiety effects .
loading...
    loading...
Cat. No.: HY-171844
CAS No.: 1086377-48-1
Target:  

iGluR

CX1739 is an orally active, blood-brain barrier permeable, low-efficacy AMPA-glutamate receptor (AMPAR) potentiator. CX1739 enhances excitatory neurotransmission by potentiating glutamate-induced excitatory currents and promoting in vivo long-term potentiation. CX1739 eliminates amphetamine-induced locomotor activity, reverses opioid-, pentobarbital- and ethanol-induced respiratory depression, and exerts pro-cognitive effects in animals. CX1739 impairs motor function recovery and increases the risk of post-injury complications. CX1739 can be used in research related to attention-deficit/hyperactivity disorder, dementia, respiratory depression and spinal cord injury .
loading...
    loading...
Cat. No.: HY-112781
CAS No.: 1258963-59-5
Purity:  99.85%
Synonyms: PF-04958242
Target:  

iGluR

Research Areas:  

Neurological Disease

Pesampator (PF-04958242) is a potent and highly selective positive allosteric modulator of AMPA receptor (an AMPA potentiator) with an EC50 of 310 nM and a Ki of 170 nM .
loading...
    loading...
Cat. No.: HY-122742
CAS No.: 489408-02-8
Purity:  99.83%
Target:  

iGluR

Research Areas:  

Neurological Disease

HBT1 is an effective AMPA receptor AMPA-R potentiator. HBT1 specifically binds to the ligand-binding domain (LBD) of AMPAR and enhances receptor activity only when AMPA is present., HBT1 has almost no agonistic effect (i.e., reaching the optimal concentration, and then the efficacy decreases as the concentration continues to increase) compared with traditional AMPA-R potentiator, avoiding the bell-shaped reaction of brain-derived neurotrophic factor (BDNF) production in primary neurons. HBT1 can be applicable to a wider range of neurological and psychiatric diseases (such as depression, Alzheimer's disease, etc.) .
loading...
    loading...
Cat. No.: HY-120811
CAS No.: 1488407-52-8
Target:  

iGluR

Research Areas:  

Neurological Disease

PF-04701475 is a potent AMPA receptor potentiator with an EC50 of 123 nM. PF-04701475 can be used for the study of neurological disorders .
loading...
    loading...
Cat. No.: HY-204388
CAS No.: 1358749-55-9
Target:  

iGluR Calcium Channel

Research Areas:  

Neurological Disease

TAK-137 is an AMPA receptor potentiator with weak agonistic effect. TAK-137 binds to the AMPA receptor ligand binding domain in a glutamate-dependent manner. TAK-137 potentiates AMPA-induced currents and Ca 2+ influx. TAK-137 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-10935R
CAS No.: 376594-67-1
Research Areas:  

Neurological Disease

LY450108 (Standard) is the analytical standard of LY450108 (HY-10935). This product is intended for research and analytical applications. LY450108 is a potent AMPA receptor potentiator. LY450108 has the potential for depression and ParKinson's disease research .
loading...
    loading...